Comparative Pharmacology
Head-to-head clinical analysis: PHARMASEAL SCRUB CARE versus READYPREP CHG.
Peer-Reviewed Evidence
Head-to-head clinical analysis: PHARMASEAL SCRUB CARE versus READYPREP CHG.
PHARMASEAL SCRUB CARE vs READYPREP CHG
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
PHARMASEAL SCRUB CARE is a combination topical antiseptic containing chlorhexidine gluconate and isopropyl alcohol. Chlorhexidine binds to negatively charged bacterial cell walls, disrupting membrane integrity and causing leakage of intracellular contents. Isopropyl alcohol denatures bacterial proteins and dissolves lipids, leading to rapid cell death.
Chlorhexidine gluconate disrupts microbial cell membranes, causing leakage of cytoplasmic contents and cell death. Its cationic nature binds to negatively charged bacterial cell walls, providing persistent antimicrobial activity.
No specific dosing; apply topical antiseptic as needed for surgical hand antisepsis; typical application: 5 mL per hand and forearm, scrub for 3-5 minutes, repeat as per institutional protocol.
No standard systemic dosing; used as a 4% chlorhexidine gluconate topical antiseptic solution applied once daily to entire body for preoperative skin preparation or for chlorhexidine bathing in infection prevention protocols.
None Documented
None Documented
Terminal elimination half-life is approximately 1.5–2 hours for chlorhexidine in plasma; prolonged to >24 hours in tissue compartments due to extensive protein binding and slow release.
60 minutes (terminal) in patients with normal renal function; prolonged in renal impairment.
Primarily renal excretion of unchanged chlorhexidine (<1%) and its metabolites via glomerular filtration; biliary/fecal elimination accounts for >90% as degraded products.
Renal: ~100% unchanged via glomerular filtration. No biliary or fecal elimination.
Category C
Category C
Antiseptic/Disinfectant
Antiseptic